In drug development, monitoring ALT levels is critical for assessing the safety of new compounds. Preclinical studies in animals and clinical trials in humans often measure ALT levels to detect potential liver toxicity early in the development process. Elevated ALT levels can lead to the modification of a drug's dosage, the implementation of additional safety measures, or even the discontinuation of the compound.
